Trump announces rare earth deal with China, South Korea to build nuclear-powered submarine with US support.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Trump announces rare earth deal with China, South Korea to build nuclear-powered submarine with US support.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.